Abbott Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	6,276	6,524	13,402	5,723	6,933	7,071
Depreciation & Amortization	3,163	3,116	3,218	3,243	3,267	3,538
Stock-Based Compensation	692	664	673	644	685	640
Other Adjustments	-	65	482	126	215	55
Change in Receivables	-432	-652	-691	-356	-68	-383
Changes in Inventories	30	195	-58	-232	-1,413	-456
Changes in Accounts Payable	-	954	356	-760	420	1,288
Changes in Income Taxes Payable	-	-5	-8,028	-585	-383	-908
Changes in Other Operating Activities	-443	-1,295	-796	-542	-75	-312
Operating Cash Flow	9,464	9,566	8,558	7,261	9,581	10,533
Operating Cash Flow Growth	5.74%	11.78%	17.86%	-24.21%	-9.04%	33.31%
Capital Expenditures	-2,086	-2,171	-2,207	-2,202	-1,777	-1,885
Purchases of Investments	-	-167	-169	-159	-185	-173
Proceeds from Sale of Investments	-166	3	28	43	152	77
Payments for Business Acquisitions	-19,903	-105	-	-877	-	-187
Proceeds from Business Divestments	-	-	1	40	48	134
Other Investing Activities	46	18	9	22	22	26
Investing Cash Flow	-22,276	-2,422	-2,338	-3,133	-1,740	-2,008
Long-Term Debt Issued	19,864	5	223	2	7	4
Long-Term Debt Repaid	-1,919	-1,504	-660	-2,498	-753	-48
Net Long-Term Debt Issued (Repaid)	17,945	-1,499	-437	-2,496	-746	-44
Issuance of Common Stock	225	396	264	167	167	255
Repurchase of Common Stock	-793	-893	-1,295	-1,227	-3,795	-2,299
Net Common Stock Issued (Repurchased)	-568	-497	-1,031	-1,060	-3,628	-2,044
Common Dividends Paid	-4,188	-4,116	-3,836	-3,556	-3,309	-3,202
Other Financing Activities	-89	-197	-100	21	47	-204
Financing Cash Flow	13,059	-6,309	-5,404	-7,091	-7,636	-5,494
Effect of Exchange Rate Changes on Cash and Cash Equivalents	24	71	-96	-23	-122	-70
Net Cash Flow	271	906	720	-2,986	83	2,961
Free Cash Flow	7,378	7,395	6,351	5,059	7,804	8,648
Free Cash Flow Growth	-0.23%	16.44%	25.54%	-35.17%	-9.76%	51.08%
FCF Margin	16.35%	16.68%	15.14%	12.61%	17.88%	20.08%
Free Cash Flow Per Share	4.22	4.23	3.63	2.89	4.42	4.83
Levered Free Cash Flow	24,885	5,819	5,450	2,149	6,226	8,292
Unlevered Free Cash Flow	6,607	7,000	5,528	4,485	7,019	8,520

SEC Filings: 10-K · 10-Q